Download slides - CTN Dissemination Library

More documents

Recommendations

Info

Medication-Assisted Recovery Use in conjunction with psychosocial treatment Medications for addiction can: • HHelp l patients ti t remain i in i treatment t t t longer l • Achieve complete abstinence • Help prevent relapse • Reduce frequency and amount of consumption • Help p continue to stay y committed to meeting g treatment goals and maintain long-term recovery 48
FDA Approved Medications Vivitrol ® Antabuse ® (disulfiram) ReVia ® /Depade ® (naltrexone) Vivitrol ® (disulfiram) (naltrexone) (naltrexone for extended extended-release release injectable suspension) i ) 1951 1994 2004 2006 Alcohol dependence dependence Methadose ® ReVia /Dolophine /Dolophine ® (methadone (methadone) ® /Depa /Depa de ® (naltrexone) LAAM Campral ® (acamprosate) Subutex ® /Suboxo ne ® (buprenorphine) 1964 1984 1993 2002 2010 Vivitrol ® Opioid dependence p (naltrexone ( naltrexone for extended extended-release release injectable suspension) 49
Page 1 and 2: Relapse Prevention Dennis C. Daley,
Page 3 and 4: GAlanMarlatt G. Alan Marlatt, PhD 1
Page 5 and 6: Recovery y Process Process of f ma
Page 7 and 8: 2: Understanding Relapse in Addicti
Page 9 and 10: Key Terms Addiction treatment: •
Page 11 and 12: Causes and Effects of Lapse/Relapse
Page 13 and 14: Relapse Situations Among Alcoholics
Page 15 and 16: Relapse Curves for Individuals Trea
Page 17 and 18: 3. Evidenced-based Evidenced based
Page 19 and 20: Efficacy of Multi-Site NIAAA Trial:
Page 21 and 22: % Days Abstinent A Mean Percent Day
Page 23 and 24: "Stop fighting and surrender, Jones
Page 25 and 26: 024 0.24 0.22 0.20 0.18 0.16 014 0.
Page 27 and 28: Family Intervention Studies di (Lid
Page 29 and 30: 4. Relapse Prevention Therapy or Co
Page 31 and 32: Relapse Prevention MModels d l Mar
Page 33 and 34: Relapse Prevention Counseling (Dale
Page 35 and 36: MATRIX Model Individual, group, fa
Page 37 and 38: 5. Systems Strategies to Reduce Rel
Page 39 and 40: S#1: Incorporate Strategies to Impr
Page 41 and 42: Abstinence Rates at 1-Year Follow-U
Page 43 and 44: Mean Number of Drinks Mean Drinks r
Page 45 and 46: S#3: Use Motivational Incentives S
Page 47: S#4: Offer Medication-Assisted Medi
Page 51 and 52: S#5: Involve the Family or Concerne
Page 53 and 54: S#6: Provide Integrated Care for Co
Page 55 and 56: 6. Counseling Interventions to Redu
Page 57 and 58: Identify Triggers and Cues Identif
Page 59 and 60: Strategies to Manage Cravings Reco
Page 61 and 62: Cognitive Factors Interacting on Re
Page 63 and 64: Negative Thinking Mark Twain Said.
Page 65: C#3: Identify and Manage Warning Si
Page 68 and 69: Learning g from a Relapse p What w
Page 70 and 71: C#4: Identify and Manage High High-
Page 72 and 73: Relapse p Precipitants p Negative
Page 74 and 75: Primary Negative Emotions Related t
Page 76 and 77: C#6: Identify and Manage Social Pre
Page 78 and 79: Examples of Different Ways to Condu
Page 80 and 81: Asking g for Help p Think of a time
Page 82 and 83: Improve Interpersonal and Social Sk
Page 84: Contents Understanding addiction
Page 87 and 88: “Guess what?! I think Jones has f
Page 89 and 90: C#9: Assess and Address Lifestyle I
Page 91 and 92: Lifestyle Changes PParticipate ti
Page 93 and 94: C#10: Stopping a Lapse or a Relapse
Page 95: Coping p g with a Lapse p St Stop,
Page 98 and 99:
Mark Your Calendar August 10 • C
show all

Download slides - CTN Dissemination Library

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?